Key facts
- This page summarizes Jolanda Howe's Form 4 filing for Mirum Pharmaceuticals, Inc. (MIRM).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Feb 2025, 17:30.
Jolanda Howe - 31 Jan 2025 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)
- Reporting relationship
- SVP, GLOBAL CONTROLLER
- Issuer ticker
- MIRM
- Reported as of
- 31 Jan 2025
- Net transaction value
- -$51,309
- SEC form
- 4
- Accepted by SEC
- 04 Feb 2025, 17:30:10 UTC
- Prior SEC filing
- 27 Jan 2025
- Next SEC filing
- 18 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Judit Ryvkin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jolanda Howe filed Form 4 for Mirum Pharmaceuticals, Inc. (MIRM) on 04 Feb 2025.
Change
- Previous filing in this sequence was filed on 27 Jan 2025.
- Current net transaction value: -$51,309.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MIRM
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,772
- Change %
- +50%
- Price
- Shares after
- 5,296
- Date
- 31 Jan 2025
- Ownership
- Direct
- Footnotes
- F1
MIRM
transaction
Common Stock
Sale
- Transaction value
- $51,309
- Shares
- -1,064
- Change %
- -20%
- Price
- $48.22
- Shares after
- 4,232
- Date
- 03 Feb 2025
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MIRM
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,772
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 1,771
- Date
- 31 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,772
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
Footnote F2
Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
Footnote F3
The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares vested January 31, 2025 and the remaining 1,771 shares will vest on January 31, 2026.